n-acetylsphingosine and Eye Abnormalities

n-acetylsphingosine has been researched along with Eye Abnormalities in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Igarashi, Y; Okazaki, T; Taguchi, Y; Tomimoto, H; Yabu, T; Yamaoka, S	1

Other Studies

1 other study(ies) available for n-acetylsphingosine and Eye Abnormalities

Article	Year
Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood, 2005, Jul-01, Volume: 106, Issue:1 Topics: Angiogenesis Inhibitors; Animals; DNA, Complementary; Embryo, Nonmammalian; Endothelium, Vascular; Eye Abnormalities; Humans; Lysophospholipids; Magnesium; Neuropilin-1; Oligonucleotides, Antisense; Sphingomyelin Phosphodiesterase; Sphingosine; Thalidomide; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-2; Zebrafish	2005

Article

Year

Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate.

Blood, 2005, Jul-01, Volume: 106, Issue:1

Topics: Angiogenesis Inhibitors; Animals; DNA, Complementary; Embryo, Nonmammalian; Endothelium, Vascular; Eye Abnormalities; Humans; Lysophospholipids; Magnesium; Neuropilin-1; Oligonucleotides, Antisense; Sphingomyelin Phosphodiesterase; Sphingosine; Thalidomide; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-2; Zebrafish

2005